On-Demand Webinars

  1. Evaluating The Entire Package System Under USP 382 5/18/2026

    USP 382 introduces holistic packaging evaluation, focusing on container closure integrity, functionality, and real-world conditions to ensure sterility, safety, and product reliability.

  2. Strategic Early Material Generation For Accelerated Process Development 5/14/2026

    Learn how early material generation strategies can accelerate biologics development, streamline process optimization, and enable scalable, production-relevant material supply from the earliest stages of development.

  3. Understanding The Regulatory Landscape For Ophthalmic Drug Products 5/14/2026

    Learn how evolving ophthalmic regulations, contamination control strategies, and advanced packaging solutions can help support compliance, product quality, and patient safety.

  4. Foundations And Implications For International Reference Pricing 5/14/2026

    Reforms like the U.S. Most Favored Nation model are intensifying pressure on global launch strategies. Understand the tactics that protect value while expanding access.

  5. The Growing Role Of Real-World Evidence 5/14/2026

    Regulators and HTA bodies are raising the bar on real-world evidence. Understand how JCAs, oncology registries, and EHR data are redefining what credible RWE looks like, and how to meet agency expectations.

  6. Optimizing Outcomes In ADC Manufacturing 5/13/2026

    As bioconjugates evolve, optimized conjugation and strong process and analytical strategies are essential for ensuring consistent quality, targeted characteristics, and reliable therapeutic performance.

  7. Design Scalable Downstream Processes With Practical Strategies 5/11/2026

    Downstream purification is becoming more complex as new modalities enter development. Learn how advanced analytics and chromatography strategies can support scalable, confident process development.

  8. A Systematic Approach To Assess Biologics Developability 5/8/2026

    Discover how a systematic, data-driven developability workflow can accelerate biologic formulation development, identify risks earlier, and optimize stability and manufacturability.

  9. From Insights To Impact: Predictive Models And PAT For More Efficient And Robust Biologics Manufacturing 5/8/2026

    Explore how advanced scale-up methodologies and real-time analytical technologies strengthen both drug substance and drug product manufacturing by enabling process understanding and informed decision-making.

  10. Spray Dried Biologics For Pulmonary Dosage Forms 5/8/2026

    View how spray drying enables stable, precisely engineered pulmonary powders for biologics, supporting efficient lung delivery, scalability, and preservation of molecular structure and activity.